P241 Focussing on the future: reducing barriers and improving access to IBD specialty care
C. Heisler*1, O. Kits2, S. Veldhuyzen van Zanten3, J. Jones2
1Nova Scotia Health Authority, Halifax, Canada, 2Dalhousie University, Halifax, Canada, 3University of Alberta, Edmonton, Canada
inflammatory bowel disease (IBD) is a chronic, immune-mediated disease that affects approximately two million North Americans. Canada has the highest age-adjusted incidence and prevalence rates of IBD globally. Given its cumulative prevalence, the IBD clinical burden in North America continues to grow. Limitations in accessing specialty healthcare services is not a new issue facing patients and healthcare providers. Despite this persistent problem, no research elucidating the patient perspective using qualitative approaches to compare and contrast the patient experience across diverse geographic regions has been conducted.
IBD patients (≥18 years of age) were recruited from gastroenterology clinics and communities through IBD specialists and Crohn’s and Colitis Canada. Patients were recruited from both urban and rural locales to ensure adequate representation from geographically diverse regions. Focus groups provided a powerful and more naturalistic tool through which a focussed understanding of the patient experience was derived. Co-facilitated by a researcher and a patient research partner, the focus groups were held in Nova Scotia, New Brunswick, Quebec, Ontario, Manitoba, Saskatchewan, Alberta, and British Columbia. Patient demographics were collected to contextualise observed themes. Themes were distilled through qualitative thematic analysis using Atlas.ti software to ascertain congruence or discordance of patient experiences. Eastern Canadian focus groups have been completed, with recruitment underway for the Western Canadian focus groups.
A total of 20 participants were recruited as of October 2018. The majority of participants were male (11/20, 55%) and were from urban/suburban regions (10/20, 50%). The mean age of participants was 44 years of age (SD = 12 years, range = 24–67 years). Preliminary analyses show that the main patient-identified barriers to accessing IBD care fall into the following categories: (1) Lack of multidisciplinary care (including psycho-social support), (2) Diagnostic delay, and (3) Inability to effectively receive and provide communication with healthcare providers. Solutions identified by patients included: (1) Integration of more holistic care into the clinical practice, (2) Readily accessible psychiatric and nutritional support, (3) Increased patient advocacy, and (4) Continuity and liaison through provision of a healthcare navigator resource.
Healthcare access for IBD patients is complex. It is important to not only have a robust understanding of the healthcare system structure and processes but also the significant impact these factors have on patients. Access improvement research can be best tackled through patient-centred exploration of themes related to access to care.